Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.38 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.595.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.595.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.595.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.595.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.340ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.340ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.340ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.340NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.437ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.437ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.437ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.437NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.452ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.452ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.452ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.452NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.400ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.400ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.400ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.400NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.25ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.25NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.2.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.2.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.2.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.16 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.16 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.16 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.16 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.46.1 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.46.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.46.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.46.1 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.37 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.37 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.37 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.37 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.336ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.336ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.336ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.336NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.317ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used